πŸ”Œ EV Partnership Switch to Octopus Energy & unlock exclusive smart EV charging rates Find out more β†’ Skip to main content
Onshore Wind

GlaxoSmithKline Wind Project (Turbine 4)

Shewalton Road Riverside Business Park Irvine Ayrshire, Strathclyde

GlaxoSmithKline Wind Project (Turbine 4) is a 2.5 MW onshore wind project in Scotland. The applicant or operator on record is GlaxoSmithKline. It is recorded as operational since June 2014. The determining authority is North Ayrshire, reference 12/00629/PP.…

Operational Β· Since 2014
Project stageOperating
  1. PlanningNov 2012 (completed)
  2. ConsentedJun 2013 (completed)
  3. ConstructionJan 2014 (completed)
  4. OperatingJun 2014 (current stage)
  5. Closed (not yet reached)

Status in the official register: Operational.

Official register: July 2026

Recorded status: Operational. Source record updated 2015-05-21.

Registered planning capacity; not measured generation.

DESNZ source publication Β· Search the full register Β· Definitions and coverage

2.500 MW
Registered Capacity
2014
Commissioned

πŸ“‹ Project Overview

GlaxoSmithKline Wind Project (Turbine 4) is a 2.5 MW onshore wind project in Scotland. The applicant or operator on record is GlaxoSmithKline. It is recorded as operational since June 2014. The determining authority is North Ayrshire, reference 12/00629/PP.

Site Schematic

SCOTLAND Β· ? turbines Β· ? kmΒ²

Schematic diagram β€” not to scale. Illustrative layout based on project specifications.

πŸ”§ Technical Specifications

Capacity (MW)2.500 MW

πŸ”Œ Grid Connection & Infrastructure

🏒 Development & Ownership

DeveloperGlaxoSmithKline
Owner / operatorGlaxoSmithKline
Year consented2013
Construction started2014
Commissioned / target2014
LocationShewalton Road Riverside Business Park Irvine Ayrshire, Strathclyde
RegionScotland
Coordinates55.5928668Β°N, 4.6181887Β°W

Additional published register fields

Registered technologyWind Onshore
Turbine Capacity (MW)2.5
No. of Turbines1

πŸ“… Project Timeline

2012-11-13
2013-06-19
2014-01-01
2014-06-01